Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
p27Kip1 controls cytokinesis via the regulation of citron kinase activation
Murielle P. Serres, … , Nisar P. Malek, Arnaud Besson
Murielle P. Serres, … , Nisar P. Malek, Arnaud Besson
Published February 1, 2012
Citation Information: J Clin Invest. 2012;122(3):844-858. https://doi.org/10.1172/JCI60376.
View: Text | PDF
Research Article Oncology

p27Kip1 controls cytokinesis via the regulation of citron kinase activation

  • Text
  • PDF
Abstract

p27Kip1 (p27) acts as a tumor suppressor by inhibiting cyclin–cyclin-dependent kinase (cyclin-CDK) activity. However, mice expressing a form of p27 that is unable to bind or inhibit cyclin-CDK complexes (p27CK–) have increased incidence of tumor development as compared with wild-type and p27–/– mice, revealing an oncogenic role for p27. Here, we identified a phenotype of multinucleation and polyploidy in p27CK– mice not present in p27–/– animals, suggesting a role for p27 in G2/M that is independent of cyclin-CDK regulation. Further analysis revealed that p27CK– expression caused a cytokinesis and abscission defect in mouse embryonic fibroblasts. We identified the Rho effector citron kinase (citron-K) as a p27-interacting protein in vitro and in vivo and found that p27 and citron-K colocalized at the contractile ring and mid-body during telophase and cytokinesis. Moreover, overexpression of the minimal p27-binding domain of citron-K was sufficient to rescue the phenotype caused by p27CK–. Conversely, expression of a mutant p27CK– unable to bind citron-K did not induce multinucleation. Finally, by binding to citron-K, p27 prevented the interaction of citron-K with its activator RhoA. Taken together, these data suggest a role for p27 during cytokinesis via the regulation of citron-K activity.

Authors

Murielle P. Serres, Uta Kossatz, Yong Chi, James M. Roberts, Nisar P. Malek, Arnaud Besson

×

Figure 4

The C-terminal half of p27 interacts with the HR1 domain of citron-K.

Options: View larger image (or click on image) Download as PowerPoint
The C-terminal half of p27 interacts with the HR1 domain of citron-K.
(A...
(A) Schematic representation of citron-K (Cit-K) and deletion mutants. All constructs except the Cit-ΔN mutant contain an N-terminal Myc epitope tag. S/T kinase, Ser/Thr kinase domain; CC, CC domain; Zn-F, Zn finger; PH, pleckstrin homology; CNH, citron homology; Pro-rich, proline-rich region: PDZ, PDZ binding domain. (B–E) HEK293 cells transfected with citron-K or the indicated deletion mutant were subjected to pull-down assays using GST or GST-p27 beads. The amounts of citron-K or deletion mutant bound to the beads and of transfected protein present in the extracts were detected by immunoblot using the indicated antibodies (Mα, mouse anti-; Gα, goat anti-; Rα, rabbit anti-). The amount of GST or GST-p27 used in the assays was visualized by Coomassie staining. (B and C) p27 interacts with citron-K. (D) p27 interacts with the CC domain of citron-K and more weakly with the RBD domain. (E) The HR1 domain present in the CC domain is necessary for p27 interaction. (F–I) Co-immunoprecipitations using rabbit anti-p27 (C19) (F, H, and I) or two different goat anti-citron antibodies (C20 or S20) (G). Co-immunoprecipitated proteins were detected by immunoblot with the indicated antibodies. The immunoprecipitated proteins were visualized by reprobing for mouse anti-p27 (F8) (F, H, and I) or goat anti-citron (C20) (G). Immunoblots of extracts show the level of transfected proteins in each condition. Grb2 levels were used as loading control. (F and G) p27 interacts with citron-K in vivo. (H and I) p27 interacts with all mutants containing the HR1 domain. A weaker interaction is also seen with the RBD. (J) p27 interacts with citron-K in HeLa cells. Endogenous p27 was immunoprecipitated using rabbit anti-p27 (C19) in HeLa cells. The co-immunoprecipitated citron-K was visualized using mouse anti–citron-K antibody. Endogenous levels of each protein are shown in the lower panels. Noc, nocodazole; purvA, purvalanol A; C, control. (K) p27 interacts with citron-K directly. Different amounts of recombinant His-p27 were used in pull-down assays with GST or GST-HR1-RBD beads. Immunoblot show the amount of p27 bound to the beads. The amount of GST or GST-HR1-RBD used in the assay was visualized by Coomassie staining. (L) The C-terminal half of p27 interacts with citron-K. Pull-downs were realized as in B with GST-p27WT, GST-p27NT (N-terminal, aa 1–86), and GST-p27CT (C terminal, aa 87–198).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts